Canada Life
TPST icon

Canada Life’s Tempest Therapeutics TPST Stock Holding History

Canada Life’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1
Closed -$6K – 2548
2017
Q1 		$6K Hold
1
– – ﹤0.01% 2503
2016
Q4 		$5K Hold
1
– – ﹤0.01% 2531
2016
Q3 		$25K Hold
1
– – ﹤0.01% 2452
2016
Q2 		$18K Hold
1
– – ﹤0.01% 2474
2016
Q1 		$33K Hold
1
– – ﹤0.01% 2261
2015
Q4 		$34K Hold
1
– – ﹤0.01% 2267
2015
Q3 		$30K Hold
1
– – ﹤0.01% 2252
2015
Q2 		$101K Buy
+1
New +$91.6K ﹤0.01% 1863

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Canada Life's TPST Position: Q2 2017 in Review

Canada Life sold out of Tempest Therapeutics (TPST) in Q2 2017, closing a stake of 1 share — an estimated $6K sold.

Canada Life first reported a position in TPST in Q2 2015 and held it in 8 quarters. The position peaked at $101K in Q2 2015. 54 funds tracked by Wall St. Rank hold TPST as of Q2 2017.

  • Canada Life reported no remaining Tempest Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Canada Life sold 1 Tempest Therapeutics share in Q2 2017, an estimated $6K.
  • Canada Life first reported a position in Tempest Therapeutics in Q2 2015 and held it in 8 quarters.
  • Canada Life's Tempest Therapeutics position peaked at $101K in Q2 2015.
  • 54 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2017.

Based on Canada Life's 13F filing for Q2 2017, filed 27 Jul 2017.